Literature DB >> 8944215

Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran).

D G Tincello1, M J Johnstone.   

Abstract

Ondansetron is a 5-hydroxytryptamine receptor antagonist which is known to be a highly effective anti-emetic drug for chemotherapy-associated nausea and vomiting and for postoperative nausea. We report here a case where ondansetron was used in severe hyperemesis gravidarum to avoid parenteral nutrition. The drug was used intermittently in every trimester with no apparent adverse effects on mother or infant.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8944215      PMCID: PMC2398636          DOI: 10.1136/pgmj.72.853.688

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

1.  Ondansetron and hyperemesis gravidarum.

Authors:  E Guikontes; A Spantideas; J Diakakis
Journal:  Lancet       Date:  1992-11-14       Impact factor: 79.321

2.  Ondansetron and hyperemesis gravidarum.

Authors:  M J World
Journal:  Lancet       Date:  1993-01-16       Impact factor: 79.321

Review 3.  Ondansetron in the prophylaxis of acute cisplatin-induced nausea and vomiting.

Authors:  M Marty
Journal:  Eur J Cancer Clin Oncol       Date:  1989

Review 4.  Pharmacological and anti-emetic properties of ondansetron.

Authors:  M B Tyers; K T Bunce; P P Humphrey
Journal:  Eur J Cancer Clin Oncol       Date:  1989

Review 5.  Clinical studies with ondansetron in the control of radiation-induced emesis.

Authors:  T J Priestman
Journal:  Eur J Cancer Clin Oncol       Date:  1989

6.  Ondansetron in the treatment of postoperative vomiting: a randomized, double-blind comparison with droperidol and metoclopramide.

Authors:  E Alon; S Himmelseher
Journal:  Anesth Analg       Date:  1992-10       Impact factor: 5.108

  6 in total
  11 in total

Review 1.  Hyperemesis gravidarum: current concepts and management.

Authors:  N K Kuşcu; F Koyuncu
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

Review 2.  Nausea and vomiting of pregnancy.

Authors:  Noel M Lee; Sumona Saha
Journal:  Gastroenterol Clin North Am       Date:  2011-06       Impact factor: 3.806

Review 3.  A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy.

Authors:  P Mazzotta; L A Magee
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

4.  Comparison of Efficacy of Granisetron and Promethazine in Control of Hyperemesis Gravidarum.

Authors:  Ashraf Aleyasin; Elham Saffarieh; Hassan Torkamandi; Somayeh Hanafi; Fariborz Sadeghi; Atossa Mahdavi; Fatemeh Bahmaei; Mohammadreza Javadi
Journal:  J Obstet Gynaecol India       Date:  2015-10-07

5.  Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists.

Authors:  Sophie E McGrath; Alistair Ring
Journal:  Ther Adv Med Oncol       Date:  2011-03       Impact factor: 8.168

6.  Placental transfer of ondansetron during early human pregnancy.

Authors:  Shing-Shun N Siu; Matthew T V Chan; Tze-Kin Lau
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 7.  Treatment of nausea and vomiting in pregnancy. When should it be treated and what can be safely taken?

Authors:  C Nelson-Piercy
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

Review 8.  Management of Hematologic Malignancies: Special Considerations in Pregnant Women.

Authors:  Odelia Amit; Merav Barzilai; Irit Avivi
Journal:  Drugs       Date:  2015-10       Impact factor: 9.546

9.  Treatment of hyperemesis gravidarum.

Authors:  Lindsey J Wegrzyniak; John T Repke; Serdar H Ural
Journal:  Rev Obstet Gynecol       Date:  2012

Review 10.  Ondansetron and pregnancy: Understanding the data.

Authors:  Debra Kennedy
Journal:  Obstet Med       Date:  2015-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.